New trial tests drug to control mysterious blood disorder
NCT ID NCT06240754
Summary
This study is testing whether a drug called enasidenib can safely help people with a condition called Clonal Cytopenia of Undetermined Significance (CCUS), which causes persistently low blood counts. Researchers think the drug might work by blocking a specific mutated protein found in participants. The trial will enroll about 15 adults with CCUS who have this specific genetic change to see if their blood counts improve.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLONAL CYTOPENIA OF UNDETERMINED SIGNIFICANCE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Washington University School of Medicine
RECRUITINGSt Louis, Missouri, 63110, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.